Clinical trial

Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in…

NCT00127088 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Suspended

Key facts

NCT number NCT00127088
Title Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients
Official title A Prospective Phase II of Peri-Operative Docetaxel + Laparoscopic Radical Prostatectomy in Patients With Localized Gleason 7 pT2a-pT2b Adenocarcinoma and a Risk of Relapse After Radical Prostatectomy
Lead sponsor Gustave Roussy, Cancer Campus, Grand Paris, Other
Status Suspended
Phase Phase 2
Study type Interventional
Conditions Prostate Cancer
Intervention type Drug, Procedure
Interventions docetaxel, laparoscopic radical prostatectomy
Enrollment 37
Start date Oct 1, 2004
First posted Aug 5, 2005
Last update posted Sep 11, 2006
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies